AHB-137

DRUG7 trials

Sponsors

Ausper Biopharma Co., Ltd., AusperBio Therapeutics Inc.

Conditions

Chronic Hepatitis BHepatitis B, Chronic

Phase 2

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

Active, not recruitingNCT06550128

Ausper Biopharma Co., Ltd.Hepatitis B, Chronic

Start: 2024-07-10End: 2026-06-30Updated: 2025-11-26

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

Active, not recruitingNCT06829329

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2024-12-13End: 2025-11-30Updated: 2025-09-24

A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

RecruitingNCT06993480

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-06-18End: 2026-12-01Target: 30Updated: 2025-12-29

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Active, not recruitingNCT07069569

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-05-30End: 2027-05-01Updated: 2025-11-26

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Not yet recruitingNCT07137910

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-08-27End: 2027-06-01Target: 60Updated: 2025-08-22

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Not yet recruitingNCT07370207

AusperBio Therapeutics Inc.Hepatitis B, Chronic

Start: 2026-02-02End: 2028-12-31Target: 84Updated: 2026-01-27

Phase 3

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

Active, not recruitingNCT07246889

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-08-12End: 2027-09-01Updated: 2025-12-23